George Abraham
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Immunoglobulin G | 27 | 1972 | 191 |
Why?
| T-Lymphocytes | 5 | 1984 | 182 |
Why?
| Aging | 5 | 1986 | 275 |
Why?
| Cryoglobulinemia | 5 | 1987 | 7 |
Why?
| Cryoglobulins | 10 | 1975 | 11 |
Why?
| Immunoglobulin kappa-Chains | 10 | 1974 | 14 |
Why?
| Tyrosine | 2 | 1998 | 71 |
Why?
| Protein-Tyrosine Kinases | 2 | 1998 | 77 |
Why?
| Retroviridae | 3 | 1989 | 36 |
Why?
| Antibodies, Monoclonal | 11 | 1983 | 241 |
Why?
| Immunoglobulin M | 13 | 1974 | 81 |
Why?
| Autoantibodies | 7 | 1974 | 64 |
Why?
| Epitopes | 8 | 1973 | 86 |
Why?
| Genes, Viral | 2 | 1989 | 37 |
Why?
| Apolipoproteins | 1 | 2001 | 19 |
Why?
| Human T-lymphotropic virus 1 | 2 | 1989 | 8 |
Why?
| Immunity, Cellular | 2 | 1986 | 85 |
Why?
| C-Reactive Protein | 1 | 2001 | 54 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1989 | 10 |
Why?
| Cytomegalovirus Infections | 1 | 1999 | 39 |
Why?
| Cytomegalovirus | 1 | 1999 | 42 |
Why?
| Genes, Immunoglobulin | 2 | 1987 | 28 |
Why?
| Oxidative Stress | 1 | 2002 | 119 |
Why?
| Influenza, Human | 1 | 2001 | 94 |
Why?
| Humans | 45 | 1968 | 1856 |
Why?
| Immunoglobulin Variable Region | 3 | 1984 | 22 |
Why?
| Immunoglobulin Light Chains | 3 | 1979 | 10 |
Why?
| Receptors, Fc | 5 | 1985 | 28 |
Why?
| Leucine | 1 | 1996 | 53 |
Why?
| Aged | 11 | 1986 | 988 |
Why?
| Agammaglobulinemia | 2 | 1984 | 14 |
Why?
| Immunoglobulin Idiotypes | 3 | 1978 | 6 |
Why?
| Antibodies, Anti-Idiotypic | 6 | 1974 | 35 |
Why?
| Felty's Syndrome | 3 | 1978 | 2 |
Why?
| Antibodies, Viral | 3 | 1975 | 104 |
Why?
| Adult | 14 | 1968 | 1317 |
Why?
| DNA, Viral | 3 | 1989 | 98 |
Why?
| Kirsten murine sarcoma virus | 1 | 1993 | 1 |
Why?
| Retroviridae Infections | 1 | 1993 | 7 |
Why?
| Thymidine Kinase | 1 | 1993 | 15 |
Why?
| Ganciclovir | 1 | 1993 | 18 |
Why?
| Polymorphism, Restriction Fragment Length | 2 | 1989 | 32 |
Why?
| Sarcoma, Experimental | 1 | 1993 | 21 |
Why?
| Gene Rearrangement | 2 | 1990 | 26 |
Why?
| Tumor Virus Infections | 1 | 1993 | 31 |
Why?
| Immunoglobulin Fc Fragments | 4 | 1973 | 12 |
Why?
| Oncogenes | 1 | 1993 | 24 |
Why?
| B-Lymphocytes | 4 | 1987 | 134 |
Why?
| Arthritis, Rheumatoid | 5 | 1974 | 53 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 1998 | 113 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1974 | 24 |
Why?
| Retroviridae Proteins | 1 | 1991 | 9 |
Why?
| Cell Cycle | 1 | 1993 | 121 |
Why?
| Transcription, Genetic | 2 | 1989 | 253 |
Why?
| Immunoglobulin A | 7 | 1973 | 39 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1991 | 28 |
Why?
| Immune System Diseases | 1 | 1990 | 5 |
Why?
| ZAP-70 Protein-Tyrosine Kinase | 2 | 1998 | 6 |
Why?
| Immunoglobulin Fragments | 4 | 1974 | 13 |
Why?
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 2 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1990 | 3 |
Why?
| Immunoglobulin mu-Chains | 2 | 1985 | 10 |
Why?
| Gene Rearrangement, B-Lymphocyte | 1 | 1989 | 13 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1990 | 28 |
Why?
| Sjogren's Syndrome | 2 | 1974 | 13 |
Why?
| Alleles | 1 | 1989 | 108 |
Why?
| Aged, 80 and over | 4 | 1991 | 599 |
Why?
| Polymorphism, Genetic | 1 | 1989 | 94 |
Why?
| Proto-Oncogenes | 1 | 1987 | 25 |
Why?
| Apoptosis | 1 | 1993 | 265 |
Why?
| Female | 13 | 1975 | 1643 |
Why?
| Isoelectric Focusing | 7 | 1974 | 18 |
Why?
| Blotting, Southern | 3 | 1989 | 69 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 1998 | 91 |
Why?
| Transferrin | 1 | 1986 | 22 |
Why?
| Base Sequence | 4 | 1989 | 371 |
Why?
| Cytotoxicity, Immunologic | 1 | 1986 | 54 |
Why?
| Middle Aged | 7 | 1987 | 1161 |
Why?
| Killer Cells, Natural | 1 | 1986 | 62 |
Why?
| Hemagglutination Inhibition Tests | 7 | 1968 | 28 |
Why?
| Molecular Sequence Data | 4 | 1989 | 404 |
Why?
| Paraproteinemias | 3 | 1979 | 7 |
Why?
| Proto-Oncogene Proteins | 1 | 1987 | 113 |
Why?
| Receptors, Cell Surface | 1 | 1986 | 115 |
Why?
| Protein Precursors | 2 | 1980 | 48 |
Why?
| Cell Line, Transformed | 2 | 1993 | 52 |
Why?
| Lymphocyte Activation | 2 | 1984 | 137 |
Why?
| Complement C3 | 1 | 1981 | 19 |
Why?
| Male | 8 | 1987 | 1553 |
Why?
| Antigens, CD3 | 1 | 2002 | 37 |
Why?
| Oxidative Phosphorylation | 1 | 2002 | 19 |
Why?
| Convalescence | 1 | 2001 | 15 |
Why?
| Serum Amyloid A Protein | 1 | 2001 | 15 |
Why?
| Clone Cells | 3 | 1978 | 92 |
Why?
| Animals | 10 | 1968 | 1031 |
Why?
| Myeloma Proteins | 4 | 1979 | 5 |
Why?
| Hepatitis B Vaccines | 1 | 2001 | 17 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2001 | 53 |
Why?
| Microscopy, Electron | 2 | 1987 | 178 |
Why?
| Adjuvants, Immunologic | 1 | 2001 | 73 |
Why?
| Rheumatoid Factor | 4 | 1973 | 9 |
Why?
| Amino Acid Sequence | 5 | 1978 | 319 |
Why?
| Antigen-Antibody Reactions | 5 | 1968 | 31 |
Why?
| Antigens, CD56 | 1 | 1999 | 16 |
Why?
| Antigens, CD45 | 1 | 1999 | 30 |
Why?
| HLA-DR Antigens | 1 | 1999 | 37 |
Why?
| Acute Disease | 1 | 2001 | 271 |
Why?
| Antigens, CD28 | 1 | 1999 | 25 |
Why?
| Concanavalin A | 1 | 1998 | 25 |
Why?
| Phytohemagglutinins | 1 | 1998 | 25 |
Why?
| Mitogens | 1 | 1998 | 31 |
Why?
| Biological Markers | 1 | 2001 | 262 |
Why?
| Immunotherapy | 2 | 1995 | 48 |
Why?
| T-Lymphocyte Subsets | 1 | 1999 | 70 |
Why?
| Hospitalization | 1 | 2001 | 169 |
Why?
| Down-Regulation | 1 | 1998 | 150 |
Why?
| Carbon Isotopes | 1 | 1996 | 36 |
Why?
| Infusions, Intravenous | 1 | 1996 | 87 |
Why?
| Prospective Studies | 1 | 2001 | 545 |
Why?
| Cross Reactions | 3 | 1983 | 63 |
Why?
| Phosphorylation | 1 | 1998 | 224 |
Why?
| Oligonucleotides, Antisense | 1 | 1995 | 46 |
Why?
| Binding, Competitive | 2 | 1984 | 109 |
Why?
| Cells, Cultured | 1 | 2002 | 447 |
Why?
| Erythrocytes | 3 | 1968 | 109 |
Why?
| Ovarian Neoplasms | 1 | 1995 | 64 |
Why?
| Receptors, IgG | 4 | 1985 | 30 |
Why?
| Molecular Weight | 5 | 1974 | 154 |
Why?
| Tumor Cells, Cultured | 2 | 1993 | 233 |
Why?
| Simplexvirus | 1 | 1993 | 33 |
Why?
| Monocytes | 2 | 1985 | 124 |
Why?
| Blood Platelets | 2 | 1985 | 67 |
Why?
| Genes, ras | 1 | 1993 | 24 |
Why?
| Reproducibility of Results | 1 | 1996 | 391 |
Why?
| Gene Therapy | 1 | 1995 | 89 |
Why?
| Radioimmunoprecipitation Assay | 1 | 1991 | 6 |
Why?
| Immunoglobulins | 1 | 1972 | 54 |
Why?
| Mice, Inbred BALB C | 1 | 1993 | 176 |
Why?
| Chromatography, Gel | 3 | 1972 | 61 |
Why?
| Antigens, Differentiation | 1 | 1990 | 53 |
Why?
| DNA Transposable Elements | 1 | 1990 | 23 |
Why?
| Genome, Human | 1 | 1990 | 29 |
Why?
| Primates | 1 | 1989 | 16 |
Why?
| Autoimmune Diseases | 1 | 1990 | 49 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1989 | 88 |
Why?
| Phylogeny | 1 | 1989 | 63 |
Why?
| Mice | 3 | 1984 | 623 |
Why?
| Blotting, Western | 1 | 1991 | 275 |
Why?
| gamma-Globulins | 3 | 1968 | 19 |
Why?
| Polymerase Chain Reaction | 1 | 1991 | 279 |
Why?
| Cephalothin | 1 | 1968 | 5 |
Why?
| Penicillin G | 1 | 1968 | 11 |
Why?
| Chromosome Mapping | 1 | 1989 | 107 |
Why?
| RNA, Viral | 1 | 1990 | 91 |
Why?
| Cloning, Molecular | 1 | 1989 | 183 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 1987 | 14 |
Why?
| DNA, Recombinant | 1 | 1987 | 34 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 1987 | 29 |
Why?
| Chromosome Deletion | 1 | 1987 | 46 |
Why?
| Nucleic Acid Hybridization | 1 | 1987 | 94 |
Why?
| Neoplasms | 1 | 1995 | 239 |
Why?
| Genes | 1 | 1987 | 82 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 167 |
Why?
| Receptors, Transferrin | 1 | 1986 | 14 |
Why?
| Leukemia, Erythroblastic, Acute | 1 | 1986 | 15 |
Why?
| Antibody Specificity | 2 | 1973 | 71 |
Why?
| Carcinoma, Hepatocellular | 1 | 1986 | 53 |
Why?
| Liver Neoplasms | 1 | 1986 | 97 |
Why?
| DNA | 1 | 1990 | 262 |
Why?
| Blood Physiological Phenomena | 1 | 1984 | 5 |
Why?
| Guinea Pigs | 2 | 1980 | 76 |
Why?
| Immunosuppression | 1 | 1984 | 47 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 1984 | 37 |
Why?
| Cell Line | 2 | 1986 | 375 |
Why?
| Macromolecular Substances | 2 | 1980 | 92 |
Why?
| Hybridomas | 1 | 1984 | 31 |
Why?
| Neutrophils | 1 | 1986 | 114 |
Why?
| Immune Sera | 3 | 1968 | 56 |
Why?
| Immune Tolerance | 1 | 1984 | 72 |
Why?
| Mice, Inbred Strains | 1 | 1984 | 118 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1985 | 224 |
Why?
| Immunosuppressive Agents | 1 | 1984 | 102 |
Why?
| Fibrinolysin | 1 | 1981 | 9 |
Why?
| Trypsin | 1 | 1981 | 63 |
Why?
| Hepatitis B Antibodies | 1 | 2001 | 11 |
Why?
| Binding Sites, Antibody | 2 | 1974 | 28 |
Why?
| Complement C4 | 1 | 1980 | 14 |
Why?
| Infant, Newborn | 1 | 1986 | 389 |
Why?
| Antigen-Antibody Complex | 2 | 1974 | 34 |
Why?
| Peptide Fragments | 1 | 1981 | 144 |
Why?
| Bence Jones Protein | 1 | 1979 | 1 |
Why?
| Isoelectric Point | 1 | 1979 | 14 |
Why?
| Immunization | 1 | 2001 | 85 |
Why?
| Macrophages | 1 | 1981 | 148 |
Why?
| Regression Analysis | 1 | 2001 | 256 |
Why?
| Immunoglobulin gamma-Chains | 1 | 1978 | 2 |
Why?
| Chromatography, Ion Exchange | 1 | 1978 | 36 |
Why?
| Immunoglobulin lambda-Chains | 2 | 1975 | 11 |
Why?
| Double-Blind Method | 1 | 2001 | 274 |
Why?
| Immunodiffusion | 2 | 1974 | 30 |
Why?
| Ultracentrifugation | 2 | 1974 | 17 |
Why?
| Centrifugation, Density Gradient | 2 | 1974 | 48 |
Why?
| Iodine Radioisotopes | 2 | 1974 | 64 |
Why?
| Saliva | 2 | 1974 | 61 |
Why?
| Cell Transplantation | 1 | 1995 | 20 |
Why?
| Diseases in Twins | 1 | 1975 | 30 |
Why?
| Germ Cells | 1 | 1995 | 11 |
Why?
| Clinical Protocols | 1 | 1995 | 93 |
Why?
| Vaccines | 1 | 1995 | 33 |
Why?
| Purpura, Hyperglobulinemic | 1 | 1974 | 1 |
Why?
| Drug Delivery Systems | 1 | 1995 | 55 |
Why?
| Cyanogen Bromide | 1 | 1974 | 8 |
Why?
| Flow Cytometry | 2 | 1986 | 216 |
Why?
| Hemagglutination Tests | 2 | 1968 | 13 |
Why?
| Chromatography | 1 | 1973 | 33 |
Why?
| Rh-Hr Blood-Group System | 1 | 1973 | 12 |
Why?
| Mercaptoethanol | 2 | 1968 | 9 |
Why?
| Research Design | 1 | 1995 | 169 |
Why?
| Isoantibodies | 1 | 1973 | 25 |
Why?
| Antigens | 1 | 1973 | 66 |
Why?
| Genetic Vectors | 1 | 1995 | 139 |
Why?
| Multiple Myeloma | 1 | 1973 | 44 |
Why?
| Pepsin A | 1 | 1972 | 5 |
Why?
| Birefringence | 1 | 1972 | 5 |
Why?
| Ammonium Sulfate | 1 | 1972 | 7 |
Why?
| Crystallography | 1 | 1972 | 11 |
Why?
| Dialysis | 1 | 1972 | 18 |
Why?
| Models, Structural | 1 | 1972 | 42 |
Why?
| Acetic Acids | 1 | 1972 | 31 |
Why?
| Antigens, CD5 | 1 | 1990 | 11 |
Why?
| Cytokines | 1 | 1995 | 207 |
Why?
| Clinical Trials as Topic | 1 | 1995 | 251 |
Why?
| Protein Binding | 1 | 1974 | 256 |
Why?
| Coombs' Test | 1 | 1968 | 14 |
Why?
| Serologic Tests | 1 | 1968 | 24 |
Why?
| Antigens, CD | 1 | 1990 | 128 |
Why?
| Hypersensitivity, Immediate | 1 | 1968 | 11 |
Why?
| Hemolysis | 1 | 1968 | 31 |
Why?
| Platelet Aggregation | 1 | 1987 | 33 |
Why?
| Rosette Formation | 1 | 1986 | 13 |
Why?
| Genetic Variation | 1 | 1987 | 91 |
Why?
| Rabbits | 1 | 1968 | 252 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 23 |
Why?
| Immunoglobulin Fab Fragments | 1 | 1986 | 23 |
Why?
| Eosinophils | 1 | 1986 | 30 |
Why?
| Superoxides | 1 | 1986 | 36 |
Why?
| Antigens, Surface | 1 | 1986 | 51 |
Why?
| Oxidation-Reduction | 2 | 1974 | 124 |
Why?
| Membrane Proteins | 1 | 1985 | 233 |
Why?
| Species Specificity | 1 | 1980 | 186 |
Why?
| Castration | 1 | 1975 | 16 |
Why?
| Hemocyanin | 1 | 1975 | 16 |
Why?
| Blood Protein Disorders | 1 | 1975 | 9 |
Why?
| Immunoelectrophoresis | 1 | 1975 | 20 |
Why?
| Alkylation | 1 | 1975 | 7 |
Why?
| Tetanus Toxoid | 1 | 1975 | 27 |
Why?
| Hypersensitivity, Delayed | 1 | 1975 | 35 |
Why?
| Twins, Monozygotic | 1 | 1975 | 28 |
Why?
| Horses | 1 | 1975 | 18 |
Why?
| Antigens, Viral | 1 | 1975 | 53 |
Why?
| Latex Fixation Tests | 1 | 1974 | 15 |
Why?
| Spectrum Analysis | 1 | 1974 | 26 |
Why?
| Adsorption | 1 | 1974 | 36 |
Why?
| Lupus Erythematosus, Systemic | 1 | 1975 | 52 |
Why?
| Lymphocytes | 1 | 1975 | 142 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 1975 | 38 |
Why?
| Antibodies | 1 | 1974 | 159 |
Why?
| Pregnancy | 1 | 1975 | 455 |
Why?
| Breast Neoplasms | 1 | 1975 | 185 |
Why?
|
|
Abraham's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
